InvestorsHub Logo
Followers 17
Posts 2115
Boards Moderated 0
Alias Born 06/18/2007

Re: None

Thursday, 10/16/2014 7:34:45 PM

Thursday, October 16, 2014 7:34:45 PM

Post# of 27424
New Study posted today on FDA site.
Use of Extracorporeal Treatment With the Cytosorb-Adsorber for the Reduction of SIRS in Heart Surgery Patients (CASHSP)
This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified October 2014 by University of Rostock
Sponsor:
University of Rostock
Information provided by (Responsible Party):
Dr. Martin Sauer, MD, University of Rostock
ClinicalTrials.gov Identifier:
NCT02265419
First received: October 9, 2014
Last updated: October 14, 2014
Last verified: October 2014

http://clinicaltrials.gov/ct2/show?term=CytoSorb&rank=1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News